Search Filters

Search Results

Found 2 results

510(k) Data Aggregation

    K Number
    K240683
    Device Name
    Rx Knee System
    Date Cleared
    2024-09-11

    (183 days)

    Product Code
    Regulation Number
    888.3560
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K181530, K220737, K223062

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The patient should be skeletally mature to receive a knee replacement. The Rx Knee System is indicated for temporary use (maximum 180 days) as an adjunct to total knee replacement (TKR) in patients undergoing a two-stage procedure due to a septic process and where gentamicin is the most appropriate antibiotic based on the susceptibility pattern of the infecting micro-organism(s). The device is intended for use in conjunction with systemic antimicrobial therapy (standard treatment approach to an infection).

    The device is intended for use with the gentamicin-loaded cement. Palacos® G.

    The Rx Knee System is not intended for use for more than 180 days, at which time it must be explanted and a permanent device implanted or another appropriate treatment performed (e.g., resection arthroplasty, fusion etc.).

    The device is only indicated for patients who will consistently use traditional mobility assist devices (e.g., crutches, walkers, canes) throughout the implantation period, allowing basic joint mobility.

    Device Description

    The Rx Knee System is a temporary knee device consisting of femoral, all polyethylene tibial and patellar components, with femoral and tibial augments and a tibial or universal stem to accommodate for variants in patient anatomy. The femoral component is available in posterior stabilised and cruciate retaining variants intended for use with corresponding all polyethylene tibia variants that have been previously cleared as part of Signature Orthopaedics' World Knee System via K181530. The femoral and tibial components have been previously cleared as part of Signature Orthopaedics' World Knee System via K181530, K220737 and K223062. All Rx Knee System components are intended for use with FDA-cleared gentamicin-loaded bone cement.

    The device is intended to be used for patients undergoing a two-stage revision procedure for infection of a total knee implant. The Rx Knee System components are sterile, single-use devices intended for temporary use as a total knee replacement.

    Materials: Cast Cobalt Chromium (CoCr) alloy (ASTM F75 and ISO 5832-4) for the femoral component, Wrought Titanium-6Aluminium-4Vanadium ELI Alloy (Ti6Al4V ELI, ASTM F136-13) for femoral and tibial augment components, tibial stem, stem extension adapter and locking screw, Ultra-High-Molecular-Weight Polyethylene (UHMWPE) or Vit-E HXLPE for the femoral and tibial components and All-poly tibial components previously cleared as part of predicate World Knee System, and titanium nitride (TiN) diamond-like carbon (DLC) for coating femoral components which is the subject of FDA device master file no. 1647.

    AI/ML Overview

    This document is an FDA 510(k) Premarket Notification review for a medical device, the "Rx Knee System". It details the device's description, indications for use, comparison to predicate devices, and performance testing conducted to demonstrate substantial equivalence.

    However, the document does not contain specific acceptance criteria, or details of a study that proves the device meets those criteria, in the format typically used for studies validating AI/ML medical devices. The performance testing outlined here is primarily engineering evaluations and comparisons to existing predicate devices, not clinical studies with human participants against a defined ground truth for a diagnostic or predictive AI/ML model.

    Therefore, I cannot extract the requested information regarding acceptance criteria, sample sizes, expert involvement, adjudication methods, MRMC studies, standalone performance, or ground truth establishment relevant to an AI/ML device validation.

    The information provided pertains to a traditional medical device (knee prosthesis), and the "performance testing" described focuses on mechanical performance, biocompatibility, sterility, and antibiotic elution to demonstrate substantial equivalence to existing devices, which is the standard for 510(k) clearances. It does not describe a study that validates an AI/ML algorithm's performance against a clinical "ground truth".

    Ask a Question

    Ask a specific question about this device

    K Number
    K222380
    Date Cleared
    2022-10-04

    (60 days)

    Product Code
    Regulation Number
    888.3560
    Reference & Predicate Devices
    Why did this record match?
    Reference Devices :

    K181530, K220737, K160159

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The patient should be skeletally mature to receive a knee replacement. Patients should have adequate bone stock and size to support and accept the prosthesis.

    The patient's need for knee replacement should be due to one or more of the following conditions:

    • Non-inflammatory degenerative joint disease including osteoarthritis, or avascular necrosis.
    • Inflammatory degenerative joint disease including rheumatoid arthritis.
    • Functional deformity such as varus, valgus or flexion deformities.
    • Revision procedures where other treatments or devices have failed.

    Signature Orthopaedics' TriVerse Total Knee Replacement System components are indication only.

    Device Description

    The TriVerse Total Knee System is a modular total knee replacement (TKR) system consisting of a femoral component, meniscal inserts, a locking bar for the meniscal insert, a patella and a tibial baseplate with a tibial post and bolt. The femoral component and meniscal insert locking bar is manufactured from cobalt chrome. The femoral component are available as posterior stabilise and cruciate retaining variants, while meniscal inserts are available as posterior stabilised, posterior stabilised plus, cruciate retaining and anterior stabilised variants. All variants of the meniscal inserts as well as the patella components are manufactured from Vitamin-E Stabilized UHMWPE (HXLPE). The tibial post component is available as an I-Beam or Finned keel variant. The tibial base plate, bolt and post components are manufactured from titanium alloy.

    AI/ML Overview

    This document is a 510(k) premarket notification for a medical device called the "TriVerse Total Knee Replacement System." It is a submission to the FDA seeking clearance for market because the manufacturer believes it is substantially equivalent to legally marketed predicate devices.

    The document does not describe AI/ML device performance or the study that proves an AI/ML meets acceptance criteria. Instead, it focuses on the substantial equivalence of materials, design, and performance testing for a physical orthopedic implant (knee replacement system) compared to existing predicate devices.

    Therefore, I cannot extract the requested information regarding acceptance criteria and study details for an AI/ML device from this document. The provided text does not contain information about:

    1. A table of acceptance criteria and reported device performance for an AI/ML device.
    2. Sample sizes or data provenance for an AI/ML test set.
    3. Number of experts or their qualifications for establishing ground truth for an AI/ML test set.
    4. Adjudication methods for an AI/ML test set.
    5. MRMC comparative effectiveness studies for an AI/ML device, or human reader improvement with AI assistance.
    6. Standalone performance of an AI/ML algorithm.
    7. Types of ground truth used for AI/ML (expert consensus, pathology, outcomes data).
    8. Sample size for an AI/ML training set.
    9. How ground truth for an AI/ML training set was established.
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1